HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.

Abstract
Inter-alpha-inhibitor protein (IalphaIp) functions as an endogenous serine protease inhibitor in human plasma, and IalphaIp levels diminish rapidly during acute inflammatory states. One potential target for IalphaIp is furin, a cell-associated serine endopeptidase essential for the activation of protective antigen and the formation of anthrax lethal toxin (LT). IalphaIp blocks furin activity in vitro and provides significant protection against cytotoxicity for murine peritoneal macrophages exposed to up to 500 ng/ml LT. A monoclonal antibody (MAb), 69.31, that specifically blocks the enzymatic activity of IalphaIp eliminates its protective effect against LT-induced cytotoxicity. IalphaIp (30 mg/kg of body weight) administered to BALB/c mice 1 hour prior to an intravenous LT challenge resulted in 71% survival after 7 days compared with no survivors among the control animals (P < 0.001). We conclude that human IalphaIp may be an effective preventative or therapeutic agent against anthrax intoxication.
AuthorsSteven M Opal, Andrew W Artenstein, Patricia A Cristofaro, Jhung W Jhung, John E Palardy, Nicholas A Parejo, Yow-Pin Lim
JournalInfection and immunity (Infect Immun) Vol. 73 Issue 8 Pg. 5101-5 (Aug 2005) ISSN: 0019-9567 [Print] United States
PMID16041026 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Alpha-Globulins
  • Antigens, Bacterial
  • Bacterial Toxins
  • anthrax toxin
  • inter-alpha-inhibitor
  • Furin
Topics
  • Alpha-Globulins (metabolism)
  • Animals
  • Anthrax (metabolism)
  • Antigens, Bacterial
  • Bacillus anthracis (metabolism)
  • Bacterial Toxins (antagonists & inhibitors)
  • Furin (antagonists & inhibitors)
  • Humans
  • Macrophages, Peritoneal (metabolism)
  • Mice
  • Spleen (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: